Maxion Therapeutics

0 followers


Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

Industries

+2

Headquarters

Employees

Links

Org chart

Arndt Schottelius

Collapse
John Mccafferty
Co-founder And CTO
Sohaib Mir
Senior Investment Principal
Thomas Weaver
Non-executive Director
Aneesh Karatt Vellatt
Chief Scientific Officer, Board Director
Sylwia Mankowska
Director Of Operations
Lisa Negus
Financial Controller
Lucy Edwardes Jones
Board Director